Zacks Investment Research
18 Jun 2026, 17:51 UTC · 2h ago
Should You Retain Tempus AI Stock In Your Portfolio Now?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Zacks Investment Research
18 Jun 2026, 17:51 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
Tempus AI's diagnostics revenues grew 34.7% year-over-year, with MRD volume increasing approximately 500%. — Significant volume growth in new diagnostic categories suggests strong market adoption and scalability.
+0.60Data and Applications revenues rose 40.5% year-over-year to $87 million, supported by new partnerships with Merck and Gilead. — Accelerating data monetization and multi-year enterprise contracts provide high-margin recurring revenue potential.
+0.50Tempus AI reports large GAAP losses and a debt-to-equity ratio of 2.96, significantly higher than the industry average of 0.00. — Heavy losses and high leverage relative to peers increase financial risk and stock volatility.
-0.40Which stocks this story touches
Continue reading
6 related stories
Search tags
The company shows strong growth in diagnostics and data monetization, though GAAP losses and stock volatility remain concerns.
Mentioned as entering a new multi-year collaboration with Tempus AI.
Mentioned as having an expanded Lens agreement with Tempus AI.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
21m ago